Atomo Diagnostics Ltd logo

Atomo Diagnostics Ltd (AT1)

Market Open
CXA CXA
- Market Cap
- P/E Ratio
- Div Yield
674,881 Volume
0 Eps
Want to track AT1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AT1 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

Atomo Diagnostics Ltd (AT1) FAQ

On which exchange is it traded?

Atomo Diagnostics Ltd is listed on CXA.

What is its stock symbol?

The ticker symbol is AT1.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Atomo Diagnostics Ltd ever had a stock split?

No, there has never been a stock split.

Atomo Diagnostics Ltd Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. John Michael Kelly CEO
CXA Exchange
- ISIN
Australia Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Atomo Diagnostics Limited is a pioneering company in the medical device sector, recognized for its innovation and excellence in the development and commercialization of rapid diagnostic test devices. Since its inception in 2010, the company has set its headquarters in Leichhardt, Australia, and has expanded its reach to serve a global clientele. Atomo Diagnostics is committed to improving health outcomes by offering rapid, reliable, and easy-to-use diagnostic solutions for a range of medical conditions and needs.

Products and Services

  • HIV Screening Tests

    Atomo Diagnostics has developed advanced rapid diagnostic tests for HIV, designed to deliver quick and accurate results. These tests are crucial for early detection and management of HIV, empowering patients with knowledge and facilitating timely medical intervention. Their user-friendly design ensures they can be administered with ease in a variety of settings, from clinical environments to remote areas, enhancing accessibility to essential health care.

  • Pregnancy Tests

    The company offers rapid pregnancy tests that are known for their reliability, speed, and ease of use. These tests enable women to determine pregnancy status in the comfort and privacy of their homes, providing clear results in minutes. Atomo Diagnostics' pregnancy tests stand out for their accuracy and user-friendly features, making the early stages of pregnancy management more accessible to women worldwide.

  • Respiratory Tests

    Addressing the critical need for fast and reliable respiratory disease diagnostics, Atomo Diagnostics provides rapid tests tailored for the detection of various respiratory conditions. These tests are designed to support quick decision-making in treatment, helping reduce the spread of infectious diseases. With the ability to provide results swiftly, these respiratory tests play a vital role in managing and controlling outbreaks, especially in pandemic situations.

Contact Information

Address: 3-5 George Street
Phone: 61 2 9099 4750